Stories & Ideas

Featured blog
Behind the Breakthrough: Q&A with Meena Mallipeddi, AmplifyMD
Meena Mallipeddi is one of the visionary leaders behind AmplifyMD working to e...
Read more
Featured blog
The Four Ds of Digital Health
In the dynamic landscape of healthcare's digital transformation, where data ac...
Read more

Stories & Ideas

By: F-Prime Capital
Behind the Breakthrough: Q&A with Meena Mallipeddi, AmplifyMD
Read More
By: Carl Byers
The Four Ds of Digital Health
Read More
By: F-Prime Capital
Behind the Breakthrough: Q&A with Peptone, Kamil Tamiola
Read More
Structure Therapeutics
Biologics and peptides have revolutionized healthcare setting the stage for a ne...
Read More
By: F-Prime Capital
Behind the Breakthrough: Q&A with Lyn Baranowski, Avalyn Pharma
Read More
By: F-Prime Capital
Behind the Breakthrough: Q&A with Stephen Smith, NOCD
Read More
By: F-Prime Capital
F-Prime’s Summer Internship Program: Meet our 2023 interns and fellows
Read More
By: F-Prime Capital
Behind the Breakthrough: Q&A with Emanuele Ostuni, ARTBIO
Read More
Beam Therapeutics
The team developed a DNA base editing technology that enabled more precise edits...
Read More
By: Alex Pasteur, Ph.D., Martin Taylor, Ph.D.
ARTBIO: Redefining cancer care through an entirely new class of alpha radioligan...
Read More
By: Carl Byers
Why We Invested in Carrot Fertility: A global leader in fertility healthcare and...
Read More
CHARM Therapeutics
Predicting the structure and nature of protein-ligand interactions could enable ...
Read More
Denali Therapeutics
That needed to change. Through our affiliate FBRI, F-Prime has had a long-standi...
Read More
Equip
In 2019, Kristina Saffran and Dr. Erin Parks came to us with a slide deck and a ...
Read More
Prime Medicine
Using “search and replace” to address the fundamental causes of genetic disease.
Read More
Peptone
Many human proteins are intrinsically disordered and play a critical role in key...
Read More
Orchard Therapeutics
But he only had a few pieces in hand. He and his co-founders had some of the mos...
Read More
Atalanta
Achieving broad distribution of RNAi therapeutics throughout the CNS has been a ...
Read More
AviadoBio
Neurological disease remains the largest cause of disability and second leading ...
Read More
K36 Therapeutics
F-Prime has long been interested in precision medicine approaches that tackle th...
Read More
Ultragenyx
When he approached us, he was looking for an investor who would understand rare ...
Read More
Project Beacon
Boston’s life science community needed efficient, affordable, accessible and equ...
Read More
Get the latest updates
We respect your privacy.
Get the latest updates
We respect your privacy.

News

Forbes
Forbes AI 50
Read More
PR Newswire
Capital Rx Earns Accreditation from the National Committee for Quality Assurance (NCQA)
Read More
PR Newswire
Stride Launches Utah's First Independent Worker Portable Benefits Contributions Program
Read More
Yahoo Finance
Genomics plc and MassMutual's program enables more policyowners to understand health risks through innovative genetic testing
Read More
Endpoints News
Two ex-bluebird leaders launch Nvelop with $100M to tackle the biggest problem in gene editing
Read More
PR Newswire
Navigate BioPharma Services, Inc. announces collaboration with RareCyte, Inc. to provide enhanced spatial biology capabilities using the Orion™ Platform
Read More
See All News